Market Overview:
The global solid tumor cancer treatment market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of cancer, technological advancements in the field of cancer treatment, and rising awareness about early diagnosis and treatment options for various types of cancers. Based on type, the global solid tumor cancer treatment market is segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, and surgical procedures. Chemotherapy is further sub-segmented into traditional chemotherapy and novel chemotherapy regimens. By application, the market is segmented into breast cancer, cervical cancer colorectalcancer lungcancer prostatecancerand others. Breast Cancer dominates the application segment with highest share owing to high incidence rate across all regions followed by Colorectal Cancer due to rising prevalence of colorectal cancers across globe .
Product Definition:
Solid tumor cancer treatment is a medical term for the various methods used to treat tumors that are solid, as opposed to tumors that are fluid-filled. Solid tumor cancers include cancers of the breast, prostate, lung, and colon.
Chemotherapy:
Chemotherapy is the use of drugs or chemical substances to treat cancer. Chemotherapy includes a group of medical procedures used to control or kill cancer cells, either by affecting the way they grow (metastasis) or by removing the cancerous tissue. The most common types of chemotherapies are surgery, radiation therapy, and chemotherapy.
The global growth factor in solid tumor cancer treatment market size spans across four major areas: product type, source region, application type.
Targeted Therapy:
Targeted therapy is a type of chemotherapy that delivers chemicals only to cancer cells, tissues or organs that are believed to be responsible for the disease. The normal cells and tissues in the body get rid of waste products such as old skin cells, blood cells and tissue by apoptosis. However, when these normal processes go wrong due to genetic mutation or chemical toxicity then it is called malignant tumor growth.
Application Insights:
The breast cancer segment dominated the global solid tumor cancer treatment market in 2017, accounting for over 21.0% share of the overall revenue. This is owing to a high prevalence of breast carcinoma and other associated disorders such as gynecological cancers and prostate cancer in women and males, respectively. According to data published by WHO, around 1 in 8 women develop invasive breast carcinoma during their lifetime while about 1 in 6 men are estimated to be diagnosed with prostate carcinoma during their lifetime globally. Thus, rising incidence rates of these types of cancers across the globe are expected to boost product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced treatment options, and availability of well-developed healthcare infrastructure. In addition, rising incidence rates and prevalence of cancer is also expected to contribute toward regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing focus on quality healthcare services in emerging economies such as India and China along with other South East Asian countries. Furthermore, economic development coupled with government initiatives for improving public health system will boost industry size further into the future in this region. ‰â€˜The Affordable Care Act (ACA) requires coverage for certain preventive care services without additional cost sharing beginning with annual wellness visits provided by doctors under a patient's annual checkup or within one year before a procedure is scheduled.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the solid tumor cancer treatment market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This high incidence rate is expected to drive demand for novel and innovative treatments for solid tumor cancers, thereby propelling the growth of this market during the forecast period.
- Rising awareness about early detection and treatment options: There has been a rise in awareness about early detection and treatment options for various types of cancers including solid tumors among patients as well as healthcare professionals over recent years. This has led to an increase in demand for effective therapies for these cancers, which is expected to boost the growth prospects of this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Solid Tumor Cancer Treatment Market Research Report
By Type
Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures, Solid Tumor Cancer Treatmen
By Application
Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Others
By Companies
AstraZeneca, Plc., Amgen, Inc., B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company, F.Hoffman La-Roche Ltd., Merck & Co., Inc., Novartis, Pfizer, Inc., Olympus Medical Systems, Solid Tumor Cancer Treatmen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Solid Tumor Cancer Treatment Market Report Segments:
The global Solid Tumor Cancer Treatment market is segmented on the basis of:
Types
Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures, Solid Tumor Cancer Treatmen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca, Plc.
- Amgen, Inc.
- B. Braun Melsungen AG
- Bristol Myers Squibb & Company
- Eli Lilly & Company
- F.Hoffman La-Roche Ltd.
- Merck & Co., Inc.
- Novartis
- Pfizer, Inc.
- Olympus Medical Systems
- Solid Tumor Cancer Treatmen
Highlights of The Solid Tumor Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormone Therapy
- Surgical Procedures
- Solid Tumor Cancer Treatmen
- By Application:
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Solid Tumor Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Solid tumor cancer treatment typically includes surgery, chemotherapy, and radiation therapy. Surgery is used to remove the tumor. Chemotherapy is used to kill cancer cells while radiation therapy helps shrink or destroy the tumor.
Some of the major companies in the solid tumor cancer treatment market are AstraZeneca, Plc., Amgen, Inc., B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company, F.Hoffman La-Roche Ltd., Merck & Co., Inc., Novartis, Pfizer, Inc., Olympus Medical Systems, Solid Tumor Cancer Treatmen.
The solid tumor cancer treatment market is expected to register a CAGR of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Solid Tumor Cancer Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Solid Tumor Cancer Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Solid Tumor Cancer Treatment Market - Supply Chain
4.5. Global Solid Tumor Cancer Treatment Market Forecast
4.5.1. Solid Tumor Cancer Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Solid Tumor Cancer Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Solid Tumor Cancer Treatment Market Absolute $ Opportunity
5. Global Solid Tumor Cancer Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Solid Tumor Cancer Treatment Market Size and Volume Forecast by Type
5.3.1. Chemotherapy
5.3.2. Targeted Therapy
5.3.3. Immunotherapy
5.3.4. Hormone Therapy
5.3.5. Surgical Procedures
5.3.6. Solid Tumor Cancer Treatmen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Solid Tumor Cancer Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Solid Tumor Cancer Treatment Market Size and Volume Forecast by Application
6.3.1. Breast Cancer
6.3.2. Cervical Cancer
6.3.3. Colorectal Cancer
6.3.4. Lung Cancer
6.3.5. Prostate Cancer
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Solid Tumor Cancer Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Solid Tumor Cancer Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Solid Tumor Cancer Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Solid Tumor Cancer Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Solid Tumor Cancer Treatment Demand Share Forecast, 2019-2026
9. North America Solid Tumor Cancer Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Solid Tumor Cancer Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Solid Tumor Cancer Treatment Market Size and Volume Forecast by Application
9.4.1. Breast Cancer
9.4.2. Cervical Cancer
9.4.3. Colorectal Cancer
9.4.4. Lung Cancer
9.4.5. Prostate Cancer
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Solid Tumor Cancer Treatment Market Size and Volume Forecast by Type
9.7.1. Chemotherapy
9.7.2. Targeted Therapy
9.7.3. Immunotherapy
9.7.4. Hormone Therapy
9.7.5. Surgical Procedures
9.7.6. Solid Tumor Cancer Treatmen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Solid Tumor Cancer Treatment Demand Share Forecast, 2019-2026
10. Latin America Solid Tumor Cancer Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Solid Tumor Cancer Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Solid Tumor Cancer Treatment Market Size and Volume Forecast by Application
10.4.1. Breast Cancer
10.4.2. Cervical Cancer
10.4.3. Colorectal Cancer
10.4.4. Lung Cancer
10.4.5. Prostate Cancer
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Solid Tumor Cancer Treatment Market Size and Volume Forecast by Type
10.7.1. Chemotherapy
10.7.2. Targeted Therapy
10.7.3. Immunotherapy
10.7.4. Hormone Therapy
10.7.5. Surgical Procedures
10.7.6. Solid Tumor Cancer Treatmen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Solid Tumor Cancer Treatment Demand Share Forecast, 2019-2026
11. Europe Solid Tumor Cancer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Solid Tumor Cancer Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Solid Tumor Cancer Treatment Market Size and Volume Forecast by Application
11.4.1. Breast Cancer
11.4.2. Cervical Cancer
11.4.3. Colorectal Cancer
11.4.4. Lung Cancer
11.4.5. Prostate Cancer
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Solid Tumor Cancer Treatment Market Size and Volume Forecast by Type
11.7.1. Chemotherapy
11.7.2. Targeted Therapy
11.7.3. Immunotherapy
11.7.4. Hormone Therapy
11.7.5. Surgical Procedures
11.7.6. Solid Tumor Cancer Treatmen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Solid Tumor Cancer Treatment Demand Share, 2019-2026
12. Asia Pacific Solid Tumor Cancer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Solid Tumor Cancer Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Solid Tumor Cancer Treatment Market Size and Volume Forecast by Application
12.4.1. Breast Cancer
12.4.2. Cervical Cancer
12.4.3. Colorectal Cancer
12.4.4. Lung Cancer
12.4.5. Prostate Cancer
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Solid Tumor Cancer Treatment Market Size and Volume Forecast by Type
12.7.1. Chemotherapy
12.7.2. Targeted Therapy
12.7.3. Immunotherapy
12.7.4. Hormone Therapy
12.7.5. Surgical Procedures
12.7.6. Solid Tumor Cancer Treatmen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Solid Tumor Cancer Treatment Demand Share, 2019-2026
13. Middle East & Africa Solid Tumor Cancer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Solid Tumor Cancer Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Solid Tumor Cancer Treatment Market Size and Volume Forecast by Application
13.4.1. Breast Cancer
13.4.2. Cervical Cancer
13.4.3. Colorectal Cancer
13.4.4. Lung Cancer
13.4.5. Prostate Cancer
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Solid Tumor Cancer Treatment Market Size and Volume Forecast by Type
13.7.1. Chemotherapy
13.7.2. Targeted Therapy
13.7.3. Immunotherapy
13.7.4. Hormone Therapy
13.7.5. Surgical Procedures
13.7.6. Solid Tumor Cancer Treatmen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Solid Tumor Cancer Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Solid Tumor Cancer Treatment Market: Market Share Analysis
14.2. Solid Tumor Cancer Treatment Distributors and Customers
14.3. Solid Tumor Cancer Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca, Plc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Amgen, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun Melsungen AG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bristol Myers Squibb & Company
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lilly & Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. F.Hoffman La-Roche Ltd.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck & Co., Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Novartis
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pfizer, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Olympus Medical Systems
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Solid Tumor Cancer Treatmen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
